TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
0.9200
+0.0201 (2.23%)
At close: Jun 18, 2026, 4:00 PM EDT
0.9301
+0.0101 (1.10%)
After-hours: Jun 18, 2026, 7:07 PM EDT
TScan Therapeutics Employees
As of March 31, 2026, TScan Therapeutics had 139 total employees, including 138 full-time and 1 part-time employees. The number of employees decreased by 3 or -2.11% since the number was last reported on December 31, 2025.
Employees
139
Change
-3
Growth
-2.11%
Revenue / Employee
$65,727
Profits / Employee
-$894,281
Market Cap
60.12M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2026 | 139 | -3 | -2.11% | 138 | 1 |
| Dec 31, 2025 | 142 | -53 | -27.18% | 142 | 0 |
| Dec 31, 2024 | 195 | 41 | 26.62% | 194 | 1 |
| Dec 31, 2023 | 154 | 16 | 11.59% | 154 | 0 |
| Dec 31, 2022 | 138 | 33 | 31.43% | 137 | 1 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Seres Therapeutics | 66 |
| PMV Pharmaceuticals | 54 |
| Entera Bio | 22 |
| iBio, Inc. | 20 |
| Filana Therapeutics | 20 |
| Edesa Biotech | 17 |
| MiNK Therapeutics | 15 |
| Context Therapeutics | 15 |
TCRX News
- 17 days ago - TScan Therapeutics, Cellares enter agreement to evaluate TCS-101 manufacturing - TheFly
- 17 days ago - Cellares and TScan Therapeutics Announce Agreement to Evaluate Automated Manufacturing of TSC-101 for Patients with Hematologic Malignancies - Business Wire
- 4 weeks ago - TScan Therapeutics Transcript: AGM 2026 - Transcripts
- 6 weeks ago - TScan Therapeutics reports Q1 EPS (22c), consensus (17c) - TheFly
- 6 weeks ago - TScan Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 weeks ago - TScan Therapeutics Earnings release: Q1 2026 - Filings
- 6 weeks ago - TScan Therapeutics Quarterly report: Q1 2026 - Filings
- 7 weeks ago - TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 29th Annual Meeting - GlobeNewsWire